Delivery Order SPE2DB25D3005-SPE2DB25FQBSF

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Plaquenil 200 mg tablets, a medication used to treat various conditions including malaria, lupus, and rheumatoid arthritis. The contract has a ceiling value of $14,841.40 and runs through February 22, 2023. It is a firm-fixed-price delivery order, with no set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,706.79 delivery order contract is for the supply of Plaquenil 200 mg tablets. The contract has an ultimate completion date of April 5, 2023 and is a firm fixed price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Plaquenil 200 mg tablets, a medication used to treat various conditions including malaria, lupus, and rheumatoid arthritis. The contract has a ceiling value of $113,239.37 and is a Firm Fixed Price contract type, with an ultimate completion date of August 22, 2024. The contract...
This federal contract award, with the ID SPE2DB20D3101|SPE2DB22FJ6A5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,525.27 firm-fixed-price delivery order is for the supply of Plaquenil 200 mg tablets, a medication used for the treatment of malaria, lupus, and certain types of arthritis. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,222.18, is for the delivery of Plaquenil 200 mg tablets. The contract is a firm-fixed-price delivery order with a completion date of December 7, 2023. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,026.35 firm fixed-price delivery order is for the supply of Plaquenil 200 mg tablets. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This federal contract award is for the supply of Plaquenil 200 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a Delivery Order with a Firm Fixed Price pricing type. The contract has a ceiling value of $6,052.70 and a completion date of August 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,115.34 firm fixed-price delivery order is for the supply of PLAQUENIL 200 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of December 19, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,820.34 firm fixed-price delivery order covers the supply of Plaquenil 200 mg tablets to support federal healthcare programs, with a completion date of September 2, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,101.97 firm fixed-price delivery order is for the pharmaceutical product Plaquenil 200 mg Tablet, with a completion date of June 5, 2023. The contract was awarded on June 2, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB25D3005
    Indefinite Delivery Contract
  • SPE2DB25D3005-SPE2DB25FQBSF
    Delivery Order

This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,529.91 firm fixed-price contract is for the supply of Plaquenil 200 mg tablets, a medication commonly used to treat malaria, lupus, and rheumatoid arthritis.

The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC enables efficient government procurement of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other medical equipment, to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award does not have a set-aside designation, indicating it was awarded through open competition.

Generated 4/21/25, 3:50 AM